Envestnet Asset Management’s Virtus LifeSci Biotech Clinical Trials ETF BBC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-9,508
| Closed | -$488K | – | 3636 |
|
|
2021
Q1 | $488K | Buy |
9,508
+590
| +7% | +$30.3K | ﹤0.01% | 2858 |
|
|
2020
Q4 | $442K | Sell |
8,918
-3,566
| -29% | -$177K | ﹤0.01% | 2722 |
|
|
2020
Q3 | $487K | Buy |
12,484
+1,539
| +14% | +$60K | ﹤0.01% | 2477 |
|
|
2020
Q2 | $473K | Buy |
10,945
+1,020
| +10% | +$44.1K | ﹤0.01% | 2461 |
|
|
2020
Q1 | $291K | Buy |
+9,925
| New | +$291K | ﹤0.01% | 2563 |
|
|
2018
Q3 | – | Sell |
-206,663
| Closed | -$6.76M | – | 1363 |
|
|
2018
Q2 | $6.76M | Buy |
206,663
+143,611
| +228% | +$4.69M | 0.02% | 413 |
|
|
2018
Q1 | $1.98M | Buy |
63,052
+62,714
| +18,554% | +$1.97M | 0.01% | 713 |
|
|
2017
Q4 | $10K | Buy |
+338
| New | +$10K | ﹤0.01% | 2623 |
|
|
2017
Q3 | – | Sell |
-338
| Closed | -$8K | – | 2917 |
|
|
2017
Q2 | $8K | Hold |
338
| – | – | ﹤0.01% | 2741 |
|
|
2017
Q1 | $8K | Hold |
338
| – | – | ﹤0.01% | 2815 |
|
|
2016
Q4 | $6K | Buy |
+338
| New | +$6K | ﹤0.01% | 2839 |
|